ArticleThe Journal of clinical endocrinology and metabolism2021

Dual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease.

S T SharmaPubMed ↗Publisher ↗

No numbers read from the abstract.